Back to Authors

Peoples, Michael D

0000-0001-5233-2603

Mayo Clinic

Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Citations 1

ZEB1 suppression sensitizes KRAS mutant cancers to MEK inhibition by an IL17RD-dependent mechanism

Science Translational Medicine | March 13, 2019 | Volume: 11 | Issue: 483 | Pages: No page available

10.1126/scitranslmed.aaq1238 | PMID 30867319

Suppression of ZEB1 through miR-200 expression or HDAC inhibition with mocetinostat sensitizes resistant KRAS mutant lung cancers to MEK inhibition.